Vitamin D3 supplementation alleviates chemically-induced cirrhosis-associated hepatocarcinogenesis
Autor(a) principal: | |
---|---|
Data de Publicação: | 2022 |
Outros Autores: | , , , , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Repositório Institucional da UNESP |
Texto Completo: | http://dx.doi.org/10.1016/j.jsbmb.2021.106022 http://hdl.handle.net/11449/229908 |
Resumo: | Vitamin D3 (VD3) deficiency has been associated with increased risk for cirrhosis and hepatocellular carcinoma, a highly incident malignant neoplasia worldwide. On the other hand, VD3 supplementation has shown some beneficial effects in clinical studies and rodent models of chronic liver disease. However, preventive effects of dietary VD3 supplementation in cirrhosis-associated hepatocarcinogenesis is still unknow. To investigate this purpose, male Wistar rats submitted to a combined diethylnitrosamine- and thioacetamide-induced model were concomitantly supplemented with VD3 (5,000 and 10,000 IU/kg diet) for 25 weeks. Liver samples were collected for histological, biochemical and molecular analysis. Serum samples were used to measure 25-hydroxyvitamin D [25(OH)D] and alanine aminotransferase levels. Both VD3 interventions decreased hepatic collagen deposition and pro-inflammatory p65 protein levels, while increased hepatic antioxidant catalase and glutathione peroxidase activities and serum 25(OH)D, without a clear dose-response effect. Nonetheless, only the highest concentration of VD3 increased hepatic protein levels of VD receptor, while decreased the number of large preneoplastic glutathione-S-transferase- (>0.5 mm²) and keratin 8/18-positive lesions, as well the multiplicity of hepatocellular adenomas. Moreover, this intervention increased hepatic antioxidant Nrf2 protein levels and glutathione-S-transferase activity. In summary, dietary VD3 supplementation - in special the highest intervention - showed antifibrotic and antineoplastic properties in chemically-induced cirrhosis-associated hepatocarcinogenesis. The positive modulation of Nrf2 antioxidant axis may be mechanistically involved with these beneficial effects, and may guide future clinical studies. |
id |
UNSP_a67dbe61d279717a545004acc71c1d1b |
---|---|
oai_identifier_str |
oai:repositorio.unesp.br:11449/229908 |
network_acronym_str |
UNSP |
network_name_str |
Repositório Institucional da UNESP |
repository_id_str |
2946 |
spelling |
Vitamin D3 supplementation alleviates chemically-induced cirrhosis-associated hepatocarcinogenesisChemopreventionCirrhosisDiethylnitrosamineLiver cancerThioacetamideVitamin D3Vitamin D3 (VD3) deficiency has been associated with increased risk for cirrhosis and hepatocellular carcinoma, a highly incident malignant neoplasia worldwide. On the other hand, VD3 supplementation has shown some beneficial effects in clinical studies and rodent models of chronic liver disease. However, preventive effects of dietary VD3 supplementation in cirrhosis-associated hepatocarcinogenesis is still unknow. To investigate this purpose, male Wistar rats submitted to a combined diethylnitrosamine- and thioacetamide-induced model were concomitantly supplemented with VD3 (5,000 and 10,000 IU/kg diet) for 25 weeks. Liver samples were collected for histological, biochemical and molecular analysis. Serum samples were used to measure 25-hydroxyvitamin D [25(OH)D] and alanine aminotransferase levels. Both VD3 interventions decreased hepatic collagen deposition and pro-inflammatory p65 protein levels, while increased hepatic antioxidant catalase and glutathione peroxidase activities and serum 25(OH)D, without a clear dose-response effect. Nonetheless, only the highest concentration of VD3 increased hepatic protein levels of VD receptor, while decreased the number of large preneoplastic glutathione-S-transferase- (>0.5 mm²) and keratin 8/18-positive lesions, as well the multiplicity of hepatocellular adenomas. Moreover, this intervention increased hepatic antioxidant Nrf2 protein levels and glutathione-S-transferase activity. In summary, dietary VD3 supplementation - in special the highest intervention - showed antifibrotic and antineoplastic properties in chemically-induced cirrhosis-associated hepatocarcinogenesis. The positive modulation of Nrf2 antioxidant axis may be mechanistically involved with these beneficial effects, and may guide future clinical studies.Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES)São Paulo State University (UNESP) Biosciences Institute Department of Structural and Functional BiologySão Paulo State University (UNESP) Medical School Department of PathologySão Paulo State University (UNESP) Biosciences Institute Department of Chemical and Biological SciencesUniversity of São Paulo (USP) School of Veterinary Medicine and Animal Science Department of PathologySão Paulo State University (UNESP) Biosciences Institute Department of Structural and Functional BiologySão Paulo State University (UNESP) Medical School Department of PathologySão Paulo State University (UNESP) Biosciences Institute Department of Chemical and Biological SciencesFAPESP: # 2012/03964-8CAPES: 2013-2016Universidade Estadual Paulista (UNESP)Universidade de São Paulo (USP)Goto, Renata L. [UNESP]Tablas, Mariana B. [UNESP]Prata, Gabriel B. [UNESP]Espírito Santo, Sara G. [UNESP]Fernandes, Ana Angélica H. [UNESP]Cogliati, BrunoBarbisan, Luis F. [UNESP]Romualdo, Guilherme R. [UNESP]2022-04-29T08:36:37Z2022-04-29T08:36:37Z2022-01-01info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articlehttp://dx.doi.org/10.1016/j.jsbmb.2021.106022Journal of Steroid Biochemistry and Molecular Biology, v. 215.1879-12200960-0760http://hdl.handle.net/11449/22990810.1016/j.jsbmb.2021.1060222-s2.0-85119337391Scopusreponame:Repositório Institucional da UNESPinstname:Universidade Estadual Paulista (UNESP)instacron:UNESPengJournal of Steroid Biochemistry and Molecular Biologyinfo:eu-repo/semantics/openAccess2024-09-03T13:15:04Zoai:repositorio.unesp.br:11449/229908Repositório InstitucionalPUBhttp://repositorio.unesp.br/oai/requestrepositoriounesp@unesp.bropendoar:29462024-09-03T13:15:04Repositório Institucional da UNESP - Universidade Estadual Paulista (UNESP)false |
dc.title.none.fl_str_mv |
Vitamin D3 supplementation alleviates chemically-induced cirrhosis-associated hepatocarcinogenesis |
title |
Vitamin D3 supplementation alleviates chemically-induced cirrhosis-associated hepatocarcinogenesis |
spellingShingle |
Vitamin D3 supplementation alleviates chemically-induced cirrhosis-associated hepatocarcinogenesis Goto, Renata L. [UNESP] Chemoprevention Cirrhosis Diethylnitrosamine Liver cancer Thioacetamide Vitamin D3 |
title_short |
Vitamin D3 supplementation alleviates chemically-induced cirrhosis-associated hepatocarcinogenesis |
title_full |
Vitamin D3 supplementation alleviates chemically-induced cirrhosis-associated hepatocarcinogenesis |
title_fullStr |
Vitamin D3 supplementation alleviates chemically-induced cirrhosis-associated hepatocarcinogenesis |
title_full_unstemmed |
Vitamin D3 supplementation alleviates chemically-induced cirrhosis-associated hepatocarcinogenesis |
title_sort |
Vitamin D3 supplementation alleviates chemically-induced cirrhosis-associated hepatocarcinogenesis |
author |
Goto, Renata L. [UNESP] |
author_facet |
Goto, Renata L. [UNESP] Tablas, Mariana B. [UNESP] Prata, Gabriel B. [UNESP] Espírito Santo, Sara G. [UNESP] Fernandes, Ana Angélica H. [UNESP] Cogliati, Bruno Barbisan, Luis F. [UNESP] Romualdo, Guilherme R. [UNESP] |
author_role |
author |
author2 |
Tablas, Mariana B. [UNESP] Prata, Gabriel B. [UNESP] Espírito Santo, Sara G. [UNESP] Fernandes, Ana Angélica H. [UNESP] Cogliati, Bruno Barbisan, Luis F. [UNESP] Romualdo, Guilherme R. [UNESP] |
author2_role |
author author author author author author author |
dc.contributor.none.fl_str_mv |
Universidade Estadual Paulista (UNESP) Universidade de São Paulo (USP) |
dc.contributor.author.fl_str_mv |
Goto, Renata L. [UNESP] Tablas, Mariana B. [UNESP] Prata, Gabriel B. [UNESP] Espírito Santo, Sara G. [UNESP] Fernandes, Ana Angélica H. [UNESP] Cogliati, Bruno Barbisan, Luis F. [UNESP] Romualdo, Guilherme R. [UNESP] |
dc.subject.por.fl_str_mv |
Chemoprevention Cirrhosis Diethylnitrosamine Liver cancer Thioacetamide Vitamin D3 |
topic |
Chemoprevention Cirrhosis Diethylnitrosamine Liver cancer Thioacetamide Vitamin D3 |
description |
Vitamin D3 (VD3) deficiency has been associated with increased risk for cirrhosis and hepatocellular carcinoma, a highly incident malignant neoplasia worldwide. On the other hand, VD3 supplementation has shown some beneficial effects in clinical studies and rodent models of chronic liver disease. However, preventive effects of dietary VD3 supplementation in cirrhosis-associated hepatocarcinogenesis is still unknow. To investigate this purpose, male Wistar rats submitted to a combined diethylnitrosamine- and thioacetamide-induced model were concomitantly supplemented with VD3 (5,000 and 10,000 IU/kg diet) for 25 weeks. Liver samples were collected for histological, biochemical and molecular analysis. Serum samples were used to measure 25-hydroxyvitamin D [25(OH)D] and alanine aminotransferase levels. Both VD3 interventions decreased hepatic collagen deposition and pro-inflammatory p65 protein levels, while increased hepatic antioxidant catalase and glutathione peroxidase activities and serum 25(OH)D, without a clear dose-response effect. Nonetheless, only the highest concentration of VD3 increased hepatic protein levels of VD receptor, while decreased the number of large preneoplastic glutathione-S-transferase- (>0.5 mm²) and keratin 8/18-positive lesions, as well the multiplicity of hepatocellular adenomas. Moreover, this intervention increased hepatic antioxidant Nrf2 protein levels and glutathione-S-transferase activity. In summary, dietary VD3 supplementation - in special the highest intervention - showed antifibrotic and antineoplastic properties in chemically-induced cirrhosis-associated hepatocarcinogenesis. The positive modulation of Nrf2 antioxidant axis may be mechanistically involved with these beneficial effects, and may guide future clinical studies. |
publishDate |
2022 |
dc.date.none.fl_str_mv |
2022-04-29T08:36:37Z 2022-04-29T08:36:37Z 2022-01-01 |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://dx.doi.org/10.1016/j.jsbmb.2021.106022 Journal of Steroid Biochemistry and Molecular Biology, v. 215. 1879-1220 0960-0760 http://hdl.handle.net/11449/229908 10.1016/j.jsbmb.2021.106022 2-s2.0-85119337391 |
url |
http://dx.doi.org/10.1016/j.jsbmb.2021.106022 http://hdl.handle.net/11449/229908 |
identifier_str_mv |
Journal of Steroid Biochemistry and Molecular Biology, v. 215. 1879-1220 0960-0760 10.1016/j.jsbmb.2021.106022 2-s2.0-85119337391 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
Journal of Steroid Biochemistry and Molecular Biology |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.source.none.fl_str_mv |
Scopus reponame:Repositório Institucional da UNESP instname:Universidade Estadual Paulista (UNESP) instacron:UNESP |
instname_str |
Universidade Estadual Paulista (UNESP) |
instacron_str |
UNESP |
institution |
UNESP |
reponame_str |
Repositório Institucional da UNESP |
collection |
Repositório Institucional da UNESP |
repository.name.fl_str_mv |
Repositório Institucional da UNESP - Universidade Estadual Paulista (UNESP) |
repository.mail.fl_str_mv |
repositoriounesp@unesp.br |
_version_ |
1810021380578607104 |